收藏切换
New Progress in the Control of Nitrosamine Impurities in Chemical Drugs
收藏切换
Xuan LIU1, Jingjing ZHU2, Zheng CHEN3, Yueying WANG4
Chinese Journal of Pharmaceuticals | 2024, 55(6) : 770 - 776
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2024, 55(6): 770-776
• Review •
New Progress in the Control of Nitrosamine Impurities in Chemical Drugs
Full
Xuan LIU1, Jingjing ZHU2, Zheng CHEN3, Yueying WANG4
Affiliations
  • 1.Taizhou Huangyan District Center for ADR Monitoring, Taizhou 318020
  • 2.Taizhou Institute for Food and Drug Control, Taizhou 317700
  • 3.Taizhou Administration for Market Regulation, Taizhou 317700
  • 4.Taizhou Pharmaceutical Association, Taizhou 317700
Published: 2024-06-10 doi: 10.16522/j.cnki.cjph.2024.06.004
Outline
收藏切换

In view of the discovery of nitrosamine impurities in angiotensinⅡ receptor antagonists, histamine 2 receptor antagonists, antimicrobial drugs, antidiabetic drugs and other drugs, global regulatory agencies have significantly increased their supervision on nitrosamine impurities. Regulatory agencies in various countries have successively issued the corresponding guiding documents, developed risk assessment methods, and proposed control strategies for nitrosamine impurities in drugs. China has also successively introduced a series of guiding documents that are in line with the international standards to control nitrosamine impurities. However, in practical work, there are still difficulties in the generation pathways, risk assessment, and control strategies for nitrosamine impurities. This article mainly introduces the possible nitrosation pathways and formation causes of nitrosamine impurities in chemical drugs, as well as the overall requirements for the analysis methods. And the risk assessment and control strategies for nitrosamine impurities in chemical drugs proposed by the regulatory agencies in various countries are summarized, which can provide a reference for further research and control of nitrosamine impurities.

nitrosamine impurity  /  chemical drug  /  quality control  /  risk assessment  /  control strategy  /  research progress
刘璇, 朱晶晶, 陈正, 王月莹. 化学药品中亚硝胺类杂质控制研究的新进展. 中国医药工业杂志, 2024 , 55 (6) : 770 -776 . DOI: 10.16522/j.cnki.cjph.2024.06.004
Xuan LIU, Jingjing ZHU, Zheng CHEN, Yueying WANG. New Progress in the Control of Nitrosamine Impurities in Chemical Drugs[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (6) : 770 -776 . DOI: 10.16522/j.cnki.cjph.2024.06.004
Year 2024 volume 55 Issue 6
24
4
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2024.06.004
  • Receive Date:2023-08-01
  • Online Date:2026-11-18
  • Published:2024-06-10
Article Data
Affiliations
History
  • Received:2023-08-01
Affiliations
    1.Taizhou Huangyan District Center for ADR Monitoring, Taizhou 318020
    2.Taizhou Institute for Food and Drug Control, Taizhou 317700
    3.Taizhou Administration for Market Regulation, Taizhou 317700
    4.Taizhou Pharmaceutical Association, Taizhou 317700
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.06.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT